VRDNViridian Therapeutics, Inc.
What is the market doing?
The market is leaning against it: in a downtrend (−20% vs 200-day) and a crowded short (+19% of shares).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 29). Price is −20% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How VRDN is trading
Viridian Therapeutics, Inc. is −3.9% over the past year while the S&P 500 is +18%: 22 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −20%
vs 200-day average · a clear downtrend
- RSI (14)
- 29
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 45%
Below its 52-week high
Details›
- Last close2026-10-09
- $18.67
- 1 monthS&P 500 +2.7%
- −16%
- 1 yearS&P 500 +18%
- −3.9%
- 5 yearsS&P 500 +88%
- +53%
- vs 50-day average$21.78
- −14%
- 52-week high
- $33.78
- 52-week low
- $13.30
- Annualised volatility
- 65%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $20M
| Year | Return |
|---|---|
| 2026 (year to date) | −40% |
| 2025 | +62% |
| 2024 | −12% |
| 2023 | −25% |
| 2022 | +48% |
| 2021 | +20% |
| 2020 | +128% |
| 2019 | −84% |
| 2018 | −71% |
| 2017 | +108% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +34% |
| Feb | 10 | 1 of 10 | −10% |
| Mar | 10 | 3 of 10 | −9.1% |
| Apr | 10 | 6 of 10 | −1.5% |
| May | 10 | 4 of 10 | +2.3% |
| Jun | 10 | 5 of 10 | +1.2% |
| Jul | 11 | 7 of 11 | +6.3% |
| Aug | 11 | 3 of 11 | −4.0% |
| Sep | 11 | 5 of 11 | +0.56% |
| Oct | 11 | 3 of 11 | −1.8% |
| Nov | 10 | 6 of 10 | +17% |
| Dec | 10 | 4 of 10 | −4.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.